A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer
Clinical trial NCT07083505 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07083505
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2026-10-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.